Investors might never grow tired of hearing stats like this: Since its 2013 IPO, shares of Zoetis (NYSE: ZTS) have delivered a total return (stock performance plus dividends) of 242%. That's well ahead of the S&P 500's 137% total return in that span, and it's doubly impressive considering the animal health leader barely pays any dividend at all, compared with the roughly 2% annual yield of the index. That's difficult to beat.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,